Study: Anti-anxiety drugs are linked to Alzheimer's disease
New research suggests that people who take benzodiazepines, a.k.a. prescription drugs like Xanax and Valium, are at higher risk for developing Alzheimer's disease.
A study published in The BMJ (formerly The British Medical Journal) this week found a link between anti-anxiety and sleeping drugs and Alzheimer's disease. Researchers studied the medication history of 1,796 elderly people with Alzheimer's, along with 7,184 controls who weren't diagnosed with Alzheimer's, and found that use of benzodiazepines increased the participants' Alzheimer's risk by as much as 51 percent.
The study, led by Sophie Billioti de Gage, a PhD student at INSERM, University of Bordeaux, tracked the participants for six years and found a strong connection between the disease and the medications. Notably, the connection was still present when researchers adjusted for consideration of factors like blood pressure, heart disease, depression, and insomnia, Time reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The good news, though, is that the study didn't find a link between Alzheimer's risk and participants who took benzodiazepines for less than three months, which is how long many of the prescriptions are used. However, long-term use of the prescriptions may have a lasting effect on your memory, so it's important to discuss your family's medical history and potential risks when starting a new medication.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Meghan DeMaria is a staff writer at TheWeek.com. She has previously worked for USA Today and Marie Claire.
-
Italian senate passes law allowing anti-abortion activists into clinics
Under The Radar Giorgia Meloni scores a political 'victory' but will it make much difference in practice?
By Chas Newkey-Burden, The Week UK Published
-
Magazine interactive crossword - May 3, 2024
Puzzles and Quizzes Issue - May 3, 2024
By The Week US Published
-
Magazine solutions - May 3, 2024
Puzzles and Quizzes Issue - May 3, 2024
By The Week US Published
-
Trump criminal trial starts with rulings, reminder
Speed Read The first day of his historic trial over hush money payments was mostly focused on jury selection
By Rafi Schwartz, The Week US Published
-
Parents of school shooter sentenced to 10-15 years
Speed Read Jennifer and James Crumbley are the first parents to be convicted in a US mass shooting
By Peter Weber, The Week US Published
-
Unlicensed dealers and black market guns
Speed Read 68,000 illegally trafficked guns were sold in a five year period, said ATF
By Peter Weber, The Week US Published
-
Bankman-Fried gets 25 years for fraud
Speed Read Former "crypto king" Sam Bankman-Fried will report to federal prison
By Peter Weber, The Week US Published
-
Feds raid Diddy homes in alleged sex trafficking case
Speed Read Homeland Security raided the properties of hip hop mogul Sean "Diddy" Combs
By Peter Weber, The Week US Published
-
'Goon Squad' cops sentenced for torturing 2 Black men
Speed Read The former Mississippi law enforcement officers pleaded guilty last year
By Peter Weber, The Week US Published
-
Michigan shooter's dad guilty of manslaughter
speed read James Crumbley failed to prevent his son from killing four students at Oxford High School in 2021
By Peter Weber, The Week US Published
-
Shooting at Chiefs victory rally kills 1, injures 21
Speed Read Gunfire broke out at the Kansas City Chiefs' Super Bowl victory parade in Missouri
By Peter Weber, The Week US Published